Cite
Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.
MLA
Zhang, Chaozai, et al. “Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.” Molecules (Basel, Switzerland), vol. 23, no. 11, Nov. 2018. EBSCOhost, https://doi.org/10.3390/molecules23113036.
APA
Zhang, C., Zhang, H., Huang, L. S., Zhu, S., Xu, Y., Zhang, X.-Q., Schooley, R. T., Yang, X., Huang, Z., & An, J. (2018). Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor. Molecules (Basel, Switzerland), 23(11). https://doi.org/10.3390/molecules23113036
Chicago
Zhang, Chaozai, Huijun Zhang, Lina S Huang, Siyu Zhu, Yan Xu, Xing-Quan Zhang, Robert T Schooley, Xiaohong Yang, Ziwei Huang, and Jing An. 2018. “Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.” Molecules (Basel, Switzerland) 23 (11). doi:10.3390/molecules23113036.